The Institute for Research in Biomedicine was founded in 2000 with the clear and ambitious goal of advancing the study of human immunology, with particular emphasis on the mechanisms of host defense.

The IRB benefits from a wide international network of collaborations.

In addition, the IRB provides teaching and training programs for graduate students from Swiss and foreign Universities.

NewsAll news

	11.08.2016 New paper by the Cavalli Lab The dynamic basis for signal propagation in human Pin1-WW. Understanding how information transfers through large molecular assemblies is an important topic in modern... Read more / Link
	21.07.2016 Influenza A: new study presents groundbreaking pre-clinical work in developing immune therapy A research article published by reknowned scientific journal Cell presents pre-clinical work to develop a promising new antibody, MEDI8852, as a potential therapy to... Read more
	21.07.2016 NIH invests $23 million into a comprehensive HIV vaccine project : the IRB is among the grantees The IRB is part of an international team established by the Texas Biomedical Research Institute to develop multi-layered HIV defense strategy. Texas Biomedical Research... Read more
	14.07.2016 Zika virus: antibodies identified with therapeutic and diagnostic potential A team of researchers from the Institute for Research in Biomedicine (IRB, USI Università della Svizzera italiana) and the Swiss biotech company Humabs BioMed SA has... Read more
	06.06.2016 Cellular receptors for human cytomegalovirus discovered A publication in the scientific journal Nature Microbiology identifies PDGFRα as the receptor for the trimeric gHgLgO complex of Human cytomegalovirus (HCMV). The study... Read more